Wang Gui-Qian, Xie Yan-Ming, Wang Lian-Xin, Wang Qun, Jia Ping-Ping, Feng Bo
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Beijing University of Technology, Beijing 100124, China.
Zhongguo Zhong Yao Za Zhi. 2017 May;42(10):1984-1990. doi: 10.19540/j.cnki.cjcmm.20170307.010.
To analyze the drug combination characteristics of Qingkailing injection for treating abnormal inflammatory factors such as elevated white blood cells and C reactive protein in real world. The patients with Qingkailing injection for abnormal C reactive proteins and abnormal white blood cells were extracted from hospital information system (HIS) of 16 Class 3A hospitals. Then the basic information, traditional Chinese medicine and Western medicine diagnostic information, doctor's advice information, and laboratory information were analyzed; Apriori algorithm was used to construct the models, and Clementine 12.0 was used for correlation analysis to analyze the clinical medication rules and drug combination characteristics in the patients with Qingkailing injection for treatment of elevated C reactive protein and white blood cells in the real world. The results of the study showed that when Qingkailing injection was combined with one kind of western medicine and traditional Chinese medicine in treatment of patients with abnormal C reactive protein, vitamin C (159 cases, 74.30%) and Tanreqing injection (71 cases, 33.18%) were most frequently used; when it was combined with 2 kinds of traditional Chinese medicines, Xueshuantong injection plus Tanreqing injection (support degree 10.75%) were most frequently used. When Qingkailing injection was combined with one kind of western medicine and traditional Chinese medicine in treatment of patients with abnormal white blood cells, vitamin C (596 cases, 56.02%) and Ganmao Qingre granules (247 cases, 23.21%) were most frequently used; when it was combined with 2 kinds of traditional Chinese medicines, Shuanghuanglian+Ganmao Qingre granules (support degree 5.26%) were most frequently used. In the patients with abnormal C-reactive protein and white blood cells, its combinations with antibiotics and nutritional support agents were most common from the pharmacological perspective, indicating that in the treatment of abnormal C-reactive protein, white blood cells and other increased inflammatory indicators, Qingkailing injection was most frequently combined with antibiotic drugs to achieve synergistic effect.
分析清开灵注射液在真实世界中治疗白细胞升高、C反应蛋白等异常炎症因子的药物联用特征。从16家三级甲等医院的医院信息系统(HIS)中提取使用清开灵注射液治疗C反应蛋白异常和白细胞异常的患者。然后分析其基本信息、中西医诊断信息、医嘱信息及检验信息;采用Apriori算法构建模型,使用Clementine 12.0进行关联分析,以分析真实世界中使用清开灵注射液治疗C反应蛋白升高和白细胞升高患者的临床用药规律及药物联用特征。研究结果显示,清开灵注射液在治疗C反应蛋白异常患者时,联合1种西药和中药时,最常使用维生素C(159例,74.30%)和痰热清注射液(71例,33.18%);联合2种中药时,最常使用血栓通注射液加痰热清注射液(支持度10.75%)。清开灵注射液在治疗白细胞异常患者时,联合1种西药和中药时,最常使用维生素C(596例,56.02%)和感冒清热颗粒(247例,23.21%);联合2种中药时,最常使用双黄连+感冒清热颗粒(支持度5.26%)。在C反应蛋白和白细胞异常患者中,从药理角度来看,其与抗生素和营养支持剂的联用最为常见,表明在治疗C反应蛋白、白细胞等异常升高的炎症指标时,清开灵注射液最常与抗生素类药物联用以达到协同作用。